🔗 Share this article

The top legal official in Texas Paxton is suing the makers of acetaminophen, asserting the firms hid potential risks that the medication created to children's cognitive development.

The lawsuit follows thirty days after Former President Trump publicized an unverified association between taking Tylenol - also known as paracetamol - while pregnant and autism in offspring.

Paxton is taking legal action against J&J, which formerly manufactured the drug, the sole analgesic approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "deceived the public by making money from discomfort and pushing pills regardless of the potential hazards."

The manufacturer says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking countless individuals to boost earnings," Paxton, from the Republican party, said.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its online platform, the company also stated it had "consistently assessed the relevant science and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism."

Associations speaking for physicians and health professionals concur.

ACOG has stated acetaminophen - the key substance in acetaminophen - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can pose serious health risks if not addressed.

"In over twenty years of investigation on the consumption of acetaminophen in gestation, no reliable research has successfully concluded that the use of paracetamol in any period of gestation causes brain development issues in young ones," the organization commented.

The lawsuit mentions latest statements from the Trump administration in asserting the drug is allegedly unsafe.

In recent weeks, Trump generated worry from public health officials when he advised expectant mothers to "struggle intensely" not to consume Tylenol when ill.

The FDA then issued a notice that medical professionals should contemplate reducing the use of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has not been established.

Health Secretary RFK Jr, who supervises the FDA, had vowed in spring to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a short period.

But specialists warned that identifying a sole reason of autism - considered by experts to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and condition that influences how people experience and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is seeking the Senate - claims Kenvue and J&J "willfully ignored and tried to quiet the science" around acetaminophen and autism.

The case aims to force the firms "destroy any commercial messaging" that claims Tylenol is secure for women during pregnancy.

The court case echoes the grievances of a collection of mothers and fathers of children with autism spectrum disorder and ADHD who filed suit against the makers of acetaminophen in 2022.

Judicial authorities dismissed the legal action, declaring studies from the family's specialists was inconclusive.